Vimta Labs Limited

NSE VIMTALABS.NS

Vimta Labs Limited Shares (Diluted, Weighted) for the year ending March 31, 2024: 22,479,279

Vimta Labs Limited Shares (Diluted, Weighted) is 22,479,279 for the year ending March 31, 2024, a -0.37% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Vimta Labs Limited Shares (Diluted, Weighted) for the year ending March 31, 2023 was 22,562,672, a 0.01% change year over year.
Vimta Labs Limited Shares (Diluted, Weighted) for the year ending March 31, 2022 was 22,560,192, a 2.05% change year over year.
Vimta Labs Limited Shares (Diluted, Weighted) for the year ending March 31, 2021 was 22,107,810, a 0.00% change year over year.
Vimta Labs Limited Shares (Diluted, Weighted) for the year ending March 31, 2020 was 22,107,810, a 0.00% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

NSE: VIMTALABS.NS

Vimta Labs Limited

CEO	Dr. Sivalinga Prasad Vasireddi
IPO Date	Dec. 15, 2005
Location	India
Headquarters	Plot Nos. 141/2 & 142, IDA, Phase II
Employees	1,428
Sector	Health Care
Industries Biotechnology Clinical Trials Pharmaceuticals Research & Consulting

Description

Vimta Labs Limited provides contract research and testing services in India and internationally. It offers laboratory, food and water testing and analysis, preclinical and clinical research, biological molecule structural and functional analysis, environmental assessment, and clinical reference laboratory services. The company serves pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and various other industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Key trends

Past 5 years